Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms

WHO 5th Edition Classification Project

Research output: Contribution to journalReview articlepeer-review

Abstract

We review B-cell neoplasms in the 5th edition of the World Health Organization classification of hematolymphoid tumors (WHO-HEM5). The revised classification is based on a multidisciplinary approach including input from pathologists, clinicians, and other experts. The WHO-HEM5 follows a hierarchical structure allowing the use of family (class)-level definitions when defining diagnostic criteria are partially met or a complete investigational workup is not possible. Disease types and subtypes have expanded compared with the WHO revised 4th edition (WHO-HEM4R), mainly because of the expansion in genomic knowledge of these diseases. In this review, we focus on highlighting changes and updates in the classification of B-cell lymphomas, providing a comparison with WHO-HEM4R, and offering guidance on how the new classification can be applied to the diagnosis of B-cell lymphomas in routine practice.

Original languageEnglish (US)
Article number100441
JournalModern Pathology
Volume37
Issue number4
DOIs
StatePublished - Apr 2024

Keywords

  • B-cell lymphomas
  • Classification
  • fifth edition
  • World Health Organization

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms'. Together they form a unique fingerprint.

Cite this